These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 12200608

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Antiviral treatment of Coxsackie B virus infection in human pancreatic islets.
    Berg AK, Olsson A, Korsgren O, Frisk G.
    Antiviral Res; 2007 Apr; 74(1):65-71. PubMed ID: 17239967
    [Abstract] [Full Text] [Related]

  • 4. [Polio-like myelitis due to Coxsackie-Virus B 3: Course under treatment with pleconaril].
    Utzig N, Friedrich B, Burtzlaff C, Lauffer H.
    Klin Padiatr; 2003 Apr; 215(5):286-7. PubMed ID: 14520593
    [Abstract] [Full Text] [Related]

  • 5. Clinical activity of pleconaril in an experimentally induced coxsackievirus A21 respiratory infection.
    Schiff GM, Sherwood JR.
    J Infect Dis; 2000 Jan; 181(1):20-6. PubMed ID: 10608746
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Severe neonatal enteroviral hepatitis treated with pleconaril.
    Aradottir E, Alonso EM, Shulman ST.
    Pediatr Infect Dis J; 2001 Apr; 20(4):457-9. PubMed ID: 11332680
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effect of consecutive alternating administration (CAA) of a triple anti-enteroviral combination on Coxsackievirus B1 neuroinfection in mice.
    Stoyanova A, Nikolova I, Galabov AS.
    Antiviral Res; 2015 Sep; 121():138-44. PubMed ID: 26196747
    [Abstract] [Full Text] [Related]

  • 10. Therapy of coxsackie virus B3-induced myocarditis with WIN 54954 in different formulations.
    Pauksen K, Ilbäck NG, Friman G, Fohlman J.
    Scand J Infect Dis Suppl; 1993 Sep; 88():125-30. PubMed ID: 8390715
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Myocarditis and meningoencephalitis in newborn infants caused by Coxsackie virus B 3].
    LUKES J.
    Cesk Pediatr; 1959 Aug; 14():731-5. PubMed ID: 14418848
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Soluble coxsackie- and adenovirus receptor (sCAR-Fc); a highly efficient compound against laboratory and clinical strains of coxsackie-B-virus.
    Pinkert S, Dieringer B, Diedrich S, Zeichhardt H, Kurreck J, Fechner H.
    Antiviral Res; 2016 Dec; 136():1-8. PubMed ID: 27773751
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Pulmonary hemorrhage due to Coxsackievirus B infection-A call to raise suspicion of this important complication as an end-stage of enterovirus sepsis in preterm twin neonates.
    Orbach R, Mandel D, Lubetzky R, Ovental A, Haham A, Halutz O, Grisaru-Soen G.
    J Clin Virol; 2016 Sep; 82():41-45. PubMed ID: 27434146
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.